Tokyo Tape
Sign in
← Fukuda Denshi

Quarterly report · Q3

6960.TEDINET S100Q3IX
Period2022-04-01 → 2022-12-31
Filed2023-02-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥93.5bn2022-04-01 → 2022-12-31Cons.Net sales
Revenue¥132.1bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥93.1bn2021-04-01 → 2021-12-31Cons.Net sales
Operating income¥16.1bn2022-04-01 → 2022-12-31Cons.Operating income
Operating income¥15.9bn2021-04-01 → 2021-12-31Cons.Operating income
Ordinary income¥16.8bn2022-04-01 → 2022-12-31Cons.Ordinary income
Ordinary income¥23.4bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥16.3bn2021-04-01 → 2021-12-31Cons.Ordinary income
Profit before tax¥16.9bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Profit before tax¥16.8bn2021-04-01 → 2021-12-31Cons.Income before income taxes
Net income (owners)¥11.6bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥16.2bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥11.6bn2021-04-01 → 2021-12-31Cons.Profit loss attributable to owners of parent
Net income¥11.6bn2022-04-01 → 2022-12-31Cons.Profit loss
Net income¥11.6bn2021-04-01 → 2021-12-31Cons.Profit loss
Total assets¥195.2bnat 2022-12-31Cons.Assets
Total assets¥195.5bnat 2022-03-31Cons.Assets
Total assets¥183.2bnat 2021-12-31Cons.Total assets (5-year summary)
Total liabilities¥38.6bnat 2022-12-31Cons.Liabilities
Total liabilities¥45.6bnat 2022-03-31Cons.Liabilities
Net assets / equity¥156.6bnat 2022-12-31Cons.Net assets
Net assets / equity¥149.9bnat 2022-03-31Cons.Net assets
Net assets / equity¥145.2bnat 2021-12-31Cons.Net assets (5-year summary)
Cash and deposits¥63.3bnat 2022-12-31Cons.Cash and deposits
Cash and deposits¥64.1bnat 2022-03-31Cons.Cash and deposits
EPS (basic)¥383.712022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥115.282022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥536.192021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥382.892021-04-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥135.082021-10-01 → 2021-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio80.2%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio76.7%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio79.3%at 2021-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
jpcrp040300-q3r_E02304-000Consumables And Other Productsreportable segmentrevenue2022-04-01 → 2022-12-31¥25.5bn
jpcrp040300-q3r_E02304-000Consumables And Other Productsreportable segmentrevenue external2022-04-01 → 2022-12-31¥25.5bn
jpcrp040300-q3r_E02304-000Consumables And Other Productsreportable segmentsegment profit2022-04-01 → 2022-12-31¥2.9bn
jpcrp040300-q3r_E02304-000Medical Treatment Equipmentreportable segmentrevenue2022-04-01 → 2022-12-31¥40.5bn
jpcrp040300-q3r_E02304-000Medical Treatment Equipmentreportable segmentrevenue external2022-04-01 → 2022-12-31¥40.5bn
jpcrp040300-q3r_E02304-000Medical Treatment Equipmentreportable segmentsegment profit2022-04-01 → 2022-12-31¥8.9bn
jpcrp040300-q3r_E02304-000Patient Monitoring Equipmentreportable segmentrevenue2022-04-01 → 2022-12-31¥7.5bn
jpcrp040300-q3r_E02304-000Patient Monitoring Equipmentreportable segmentrevenue external2022-04-01 → 2022-12-31¥7.5bn
jpcrp040300-q3r_E02304-000Patient Monitoring Equipmentreportable segmentsegment profit2022-04-01 → 2022-12-31¥1.2bn
jpcrp040300-q3r_E02304-000Physiological Diagnostic Equipmentreportable segmentrevenue2022-04-01 → 2022-12-31¥20.0bn
jpcrp040300-q3r_E02304-000Physiological Diagnostic Equipmentreportable segmentrevenue external2022-04-01 → 2022-12-31¥20.0bn
jpcrp040300-q3r_E02304-000Physiological Diagnostic Equipmentreportable segmentsegment profit2022-04-01 → 2022-12-31¥3.0bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥93.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥93.5bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥16.1bn
jpcrp040300-q3r_E02304-000Consumables And Other Productsreportable segmentrevenue2021-04-01 → 2021-12-31¥24.5bn
jpcrp040300-q3r_E02304-000Consumables And Other Productsreportable segmentrevenue external2021-04-01 → 2021-12-31¥24.5bn
jpcrp040300-q3r_E02304-000Consumables And Other Productsreportable segmentsegment profit2021-04-01 → 2021-12-31¥3.4bn
jpcrp040300-q3r_E02304-000Medical Treatment Equipmentreportable segmentrevenue2021-04-01 → 2021-12-31¥40.4bn
jpcrp040300-q3r_E02304-000Medical Treatment Equipmentreportable segmentrevenue external2021-04-01 → 2021-12-31¥40.4bn
jpcrp040300-q3r_E02304-000Medical Treatment Equipmentreportable segmentsegment profit2021-04-01 → 2021-12-31¥8.5bn
jpcrp040300-q3r_E02304-000Patient Monitoring Equipmentreportable segmentrevenue2021-04-01 → 2021-12-31¥9.3bn
jpcrp040300-q3r_E02304-000Patient Monitoring Equipmentreportable segmentrevenue external2021-04-01 → 2021-12-31¥9.3bn
jpcrp040300-q3r_E02304-000Patient Monitoring Equipmentreportable segmentsegment profit2021-04-01 → 2021-12-31¥1.5bn
jpcrp040300-q3r_E02304-000Physiological Diagnostic Equipmentreportable segmentrevenue2021-04-01 → 2021-12-31¥18.8bn
jpcrp040300-q3r_E02304-000Physiological Diagnostic Equipmentreportable segmentrevenue external2021-04-01 → 2021-12-31¥18.8bn
jpcrp040300-q3r_E02304-000Physiological Diagnostic Equipmentreportable segmentsegment profit2021-04-01 → 2021-12-31¥2.5bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-12-31¥93.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-12-31¥93.1bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-12-31¥15.9bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 372
ItemContextValueUnit
Operating incomePrior1YTDDuration15863000000JPY
Operating incomeCurrentYTDDuration16077000000JPY
Interest income noiPrior1YTDDuration51000000JPY
Interest income noiCurrentYTDDuration51000000JPY
Dividends income noiPrior1YTDDuration111000000JPY
Dividends income noiCurrentYTDDuration145000000JPY
Foreign exchange gains noiPrior1YTDDuration94000000JPY
Foreign exchange gains noiCurrentYTDDuration306000000JPY
Gain on investments in partnership noiPrior1YTDDuration78000000JPY
Gain on investments in partnership noiCurrentYTDDuration17000000JPY
Other noiPrior1YTDDuration162000000JPY
Other noiCurrentYTDDuration201000000JPY
Non operating incomePrior1YTDDuration497000000JPY
Non operating incomeCurrentYTDDuration721000000JPY
Interest expenses noePrior1YTDDuration27000000JPY
Interest expenses noeCurrentYTDDuration26000000JPY
Loss on investments in partnership noePrior1YTDDuration4000000JPY
Loss on investments in partnership noeCurrentYTDDuration－JPY
Other noePrior1YTDDuration7000000JPY
Other noeCurrentYTDDuration6000000JPY
Non operating expensesPrior1YTDDuration40000000JPY
Non operating expensesCurrentYTDDuration33000000JPY
Ordinary incomePrior1YTDDuration16320000000JPY
Ordinary incomeCurrentYTDDuration16766000000JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration4000000JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration9000000JPY
Gain on sales of investment securities eiPrior1YTDDuration60000000JPY
Gain on sales of investment securities eiCurrentYTDDuration－JPY
Surrender value of insurance eiPrior1YTDDuration478000000JPY
Surrender value of insurance eiCurrentYTDDuration167000000JPY
Gain on extinguishment of tie in shares eiPrior1YTDDuration－JPY
Gain on extinguishment of tie in shares eiCurrentYTDDuration67000000JPY
Extraordinary incomePrior1YTDDuration543000000JPY
Extraordinary incomeCurrentYTDDuration244000000JPY
Loss on sales of noncurrent assets elPrior1YTDDuration－JPY
Loss on sales of noncurrent assets elCurrentYTDDuration14000000JPY
Impairment loss elPrior1YTDDuration16000000JPY
Impairment loss elCurrentYTDDuration59000000JPY
Loss on valuation of investment securities elPrior1YTDDuration－JPY
Loss on valuation of investment securities elCurrentYTDDuration53000000JPY
Office transfer expenses elPrior1YTDDuration33000000JPY
Office transfer expenses elCurrentYTDDuration4000000JPY
Other elPrior1YTDDuration－JPY
Other elCurrentYTDDuration0JPY
Extraordinary lossPrior1YTDDuration50000000JPY
Extraordinary lossCurrentYTDDuration133000000JPY
Income before income taxesPrior1YTDDuration16814000000JPY
Income before income taxesCurrentYTDDuration16877000000JPY
Income taxes currentPrior1YTDDuration4845000000JPY
Income taxes currentCurrentYTDDuration5159000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2021-04-01/2021-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass